MuSK agonist antibody (New York University School of Medicine)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameMuSK agonist antibody (New York University School of Medicine)
Drug Alias Namemuscle specific kinase agonist antibody (New York University School of Medicine)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionMuscle, skeletal receptor tyrosine-protein kinase agonists
TargetsMuscle, skeletal receptor tyrosine-protein kinase
Therapy Area/IndicationsAmyotrophic Lateral SclerosisMyasthenia Gravis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNew York University School Of Medicine
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNew York University School Of Medicine
Active IndicationsN/A
Inactive IndicationsAmyotrophic Lateral SclerosisMyasthenia Gravis

Other Information

ATC CodeN/A
Related LinksN/A